Molecular mechanisms of aging in MTDNA mutator mice by Edgar, Daniel Henry Sven
From DEPARTMENT OF LABORATORY MEDICINE 
Karolinska Institutet, Stockholm, Sweden 
 
 
 
 
 
MOLECULAR MECHANISMS OF AGING IN MTDNA 
MUTATOR MICE 
 
 
 
Daniel Edgar 
 
 
 
 
 
 
 
 
 
 
 
 
Stockholm 2011  
  
 
All previously published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet. Printed by Larserics Digitalprint AB. 
 
© Daniel Edgar, 2011 
ISBN 978-91-7457-442-5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do not go gentle into that good night. 
Rage, rage against the dying of the light. 
 
Dylan Thomas
 
ABSTRACT 
Mitochondria are intensely studied in the field of aging. mtDNA mutator mice have a 
proofreading deficiency in the mitochondrial DNA polymerase POLG, which causes a 
large amount of point mutations to be accumulated in mitochondrial DNA. These mice 
have mitochondrial dysfunction and experience a range of premature aging phenotypes.   
 
In this thesis we examine the molecular mechanisms behind the mitochondrial 
dysfunction and premature aging phenotypes of the mtDNA mutator mice. The main 
reason for the mitochondrial dysfunction is the inability to assemble respiratory chain 
complexes. This is due to point mutations in the mitochondrially encoded protein 
subunits of the electron transport chain. As a consequence of this, these proteins are 
rapidly broken down and lower levels of respiratory chain complexes I, III and IV are 
assembled. The vicious cycle hypothesis predicts that an increased load of mtDNA 
mutations would cause increased reactive oxygen species (ROS) production. In contrast 
to this, there is no general increase in ROS production in mtDNA mutator 
mitochondria. Rather, we observed a large decrease in ROS production from reverse 
electron transfer and a moderate increase in ROS production generated from forward 
electron transfer. On a combination of complex I and II substrates, mtDNA mutator 
mitochondria produced significantly less ROS mainly as a consequence of reduced 
ROS production from reverse electron transfer. Although ROS production was not 
increased in mtDNA mutator mice, oxidative stress poses a threat. Tissues exposed to 
ambient oxygen could not defend against oxidation to the same extent as wt tissues. 
When grown in cell culture at 20% oxygen tension mouse embryonic fibroblasts from 
mtDNA mutator mice tend to immortalize. This effect is eliminated when cells are 
grown in only 3% oxygen or on low glucose or galactose. This could possibly be due to 
altered sensitivity to ROS or a growth enabling effect of a glycolytic metabolism. 
 
As a consequence of the mitochondrial dysfunction mtDNA mutator mice have 
increased levels of UCP2. One proposed function of UCP2 is to uncouple the electron 
transport chain from the ATP synthase, by increasing proton conductance through the 
inner mitochondrial membrane. In contrast to its proposed uncoupling function, UCP2 
does not seem to mediate proton conductance in mtDNA mutator mice. However UCP2 
appears to mediate a switch to fatty acid metabolism. One major effect of UCP2 
depletion in mtDNA mutator mice is early heart pathology. This indicates that UCP2 
has a protective role in the mtDNA mutator hearts, perhaps through allowing better 
utilization of fatty acids. The mtDNA mutator mice provide insight into how mtDNA 
mutations affect mitochondria and how defective mitochondria affect the aging process.  
 
 
LIST OF PUBLICATIONS 
I.  Random point mutations with major effects on protein-coding genes are the 
driving force behind premature aging in mtDNA mutator mice. 
II.  Low capacity for mitochondrial reactive oxygen species production but 
increased susceptibility to lipid peroxidation in mtDNA mutator mice. 
III.  Random mtDNA mutations modulate proliferation capacity in mouse 
embryonic fibroblasts 
IV.  Physiological upregulation of UCP2 protects from early heart dysfunction in 
mtDNA mutator mice 
 
TABLE OF CONTENTS 
1	   Introduction ................................................................................................................. 1	  
1.1	   Mitochondria ................................................................................................... 1	  
1.1.1	   Mitochondrial DNA (mtDNA) ....................................................... 1	  
1.1.2	   A trip through the electron transport chain..................................... 2	  
1.1.3	   Mitochondrial ROS production and oxidative stress ..................... 4	  
1.2	   Uncoupling ...................................................................................................... 5	  
1.2.1	   Uncoupling proteins (UCPs)........................................................... 5	  
1.3	   Aging ............................................................................................................... 6	  
1.3.1	   Evolutionary views on aging .......................................................... 7	  
1.3.2	   Cellular senescence......................................................................... 8	  
1.3.3	   Aging theories ................................................................................. 9	  
1.3.4	   Mitochondria and Aging............................................................... 10	  
1.4	   The mtDNA mutator mouse ......................................................................... 13	  
2	   Specific aims ............................................................................................................. 15	  
3	   Results and discussion .............................................................................................. 16	  
3.1	   On Point mutations and circular molecules with large deletions ................. 16	  
3.2	   On reactive oxygen species and oxidative stress in MTDNA mutator mice21	  
3.3	   On point mutations and cellular senescence................................................. 23	  
3.4	   The role of UCP2 in mtDNA mutator mice ................................................. 25	  
4	   Acknowledgements................................................................................................... 27	  
5	   References ................................................................................................................. 29	  
 
LIST OF ABBREVIATIONS 
COX Cytochrome c oxidase 
CR Control region 
DDR DNA damage response 
DM Double mutant 
FAD Flavin adenine dinucleotide 
FCCP carbonylcyanide-p-trifluoromethoxyphenylhydrazone 
FMN Flavin mononucleotide 
GSIS Glucose stimulated insulin secretion 
mtDNA Mitochondrial DNA 
OH Origin of replication for the heavy strand 
OL Origin of replication for the light strand 
POLG Polymerase gamma 
Q Ubiquinone 
QH2 Ubiquinol 
ROS Reactive oxygen species 
SAHFs Senescence associated heterochromatic foci 
SASP Senescence associated secretory phenotype 
UCP Uncoupling protein 
 
  1 
1 INTRODUCTION 
1.1 MITOCHONDRIA 
A long, long time ago when our planet was young, an ancestor to the α-proteobacteria 
entered a eukaryotic cell (Gray, Burger et al. 1999). This union turned out to be 
beneficial for both parties. Slowly the genes were transferred from the bacteria to the 
nucleus of the eukaryote leaving in the case of mammals only 37 genes. The bacteria 
turned into what today are the mitochondria. The mitochondria are a network of double 
membraned organelles. One major function of the mitochondria is to produce ATP, the 
energy currency of the cell (figure 1). This is done by the respiratory chain, which 
works across the inner membrane pumping protons out of the matrix (the space 
enclosed by the inner membrane) to create an electrochemical gradient. This gradient is 
then used by the ATP synthase to produce ATP from ADP and Pi.  
 
ATP is used in all of the body’s processes that require energy. ATP is also produced 
outside the mitochondria, however this is a far less efficient energy producing system. 
This is because mitochondrial respiration utilizes much more of the chemical energy 
stored in fat, sugar and protein that we consume. In fact it is a breakdown of all of the 
highly energetic chemical bond previously produced by the reverse reaction that takes 
place in plants, photosynthesis. This combustion process is broken down into several 
steps allowing for the generation of useful energy limiting the production of heat. I 
addition to providing the cell with ATP, mitochondria perform several other essential 
functions. These include fatty acid metabolism, Ca2+ signalling, iron sulphur cluster 
assembly, apoptosis signalling and reactive oxygen (ROS) production. 
 
1.1.1 Mitochondrial DNA (mtDNA) 
The mammalian mitochondrial genome is composed of ∼16.5 kilobases of circular, 
double stranded DNA encoding for 2 ribosomal RNAs (rRNAs), 22 transfer RNAs and 
(tRNAs) 13 protein subunits of electron transport chain, namely ND1-ND6, ND4L,  
Cyt b, COX I-III, ATPase6 and ATPase8. The nuclear DNA encodes the rest of the 
1000-1500 mitochondrial proteins. The two strands of the mitochondrial genome differ 
in their G and C content. There is a G rich strand called the heavy strand and a C rich 
strand called the light strand. The control region (CR) contains promotors for both the 
heavy and the light strand. Both rRNAs, and all of the polypeptides except ND6 are 
encoded by the heavy strand. The genome is transcribed as a polycistronic RNA and 
tRNAs, rRNAs and mRNAs are cleaved out. In contrast to nuclear DNA there are 
many copies of mitochondrial DNA in each cell. If all of the mtDNA molecules haves 
the same sequence the state of the cell is homoplasmic. However if the molecules are 
different perhaps as the result of a mutation we have a heteroplasmic cell. The level of 
the mutation can drift to higher or lower percentages and can be inherited from the 
mother at different levels. If the mutation is deleterious a high level of the mutation 
may cause disease. 
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1.1.2 A trip through the electron transport chain 
The mammalian electron transport chain is composed of four complexes. Its main 
function is to pump protons out of the matrix into the intermembrane space to create an 
electrochemical gradient that can be utilized by the ATP synthase to produce ATP. 
Below follows a sequence of events that initiates at complex I or II and culminates at 
complex IV in the reduction of oxygen to H2O (figure 1). 
 
Complex I: Complex I or NADH dehydrogenase is the largest complex in the electron 
transport chain. Here two electrons are transferred from NADH to flavin 
mononucleotide (FMN) reducing it to form FMNH2. From FMNH2 the electrons jump 
to an iron-sulphur cluster in complex I. The electrons are then transferred to ubiquinone 
(Q). This is done in a two-step process. First the free radical semiquinone is formed, 
then the addition of the second electron results in ubiquinol (QH2). Through this 
process four protons are transferred from the mitochondrial matrix into the 
intermembrane space. 
 
Complex II: Another entry point of electrons into the electron transport chain is 
complex II or succinate dehydrogenase. This is the only complex that is entirely 
encoded by the nuclear DNA. Succinate is oxidized via flavin adenine dinucleotide 
(FAD) to form fumarate, and electrons travel through iron sulphur clusters to 
ubiquinone.  
 
Complex III: In complex III, or cytochrome bc1, ubiquinols from complex I and II are 
oxidized at the Qo site. This involves two electrons being transferred to the Qo site. 
These electrons from the Qo site are then transferred to cytochrome c via cytochrome 
c1. At the same time two other electrons are transferred from Qo to the Qi site where 
ubiquinone, is reduced to ubiquinol. The net result of these reactions is that four 
protons are removed from the matrix. 
 
Complex IV: In complex IV or cytochrome c oxidase the cytochrome c transfers four 
electrons to O2 producing two molecules of H2O and at the same time four protons are 
transported across the inner membrane from the matrix. 
 
The electron transport chain ends at complex IV but the electrochemical gradient, built 
up by the electron transport chain is used by another complex, complex V or the ATP 
synthase. Powered by the influx of protons into the mitochondrial matrix, the ATP 
synthase combines ADP and Pi into ATP, the energy currency of the cell (Nicholls and 
Ferguson 2002).   
 
Figure 1. On the opposite page. A trip through the electron transport chain showing the five complexes 
and the flow of protons, electrons and production of ATP. 
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1.1.3 Mitochondrial ROS production and oxidative stress 
Reactive oxygen species (ROS) generally refers to molecules with an unpaired electron 
but also includes hydrogen peroxide H2O2 that does not have an unpaired electron. 
These are highly reactive molecules. Uncontrolled increases in ROS levels can lead to 
chain reactions, which indiscriminately target protein, lipids, polysaccharides and 
DNA. Superoxide is the precursor of most ROS within the cell. Superoxide can be 
turned into hydrogen peroxide H2O2, either spontaneously or by superoxide dismutase. 
This in turn can be fully reduced to water, or partially reduced to form hydroxyl radical 
OH- (one of the strongest oxidants in nature) (Turrens 2003).  
 
Superoxide production: The transfer of electrons between the different complexes is 
based on the fact that the new site is more easily reduced than the old one. However 
there is always the possibility that the electron will reduce molecular oxygen. When 
this happens superoxide is formed. How much superoxide is formed depends on 
various factors such as oxygen availability (if more oxygen is present there is a greater 
chance that an oxygen molecule will capture an electron), membrane potential or what 
substrates are used to initiate the electron transport chain. The main sites of ROS 
production in the electron transport chain are complex I and complex III. ROS can be 
produced from complex I by either forward or reverse electron transfer. Forward 
electron transfer can be achieved by adding glutamate + malate or pyruvate + malate to 
isolated mitochondria. This will produce NADH for complex I and ensures that no 
succinate will be produced for complex II. On forward electron transfer, superoxide 
will be produced by complex I. This production can be augmented by the complex I 
specific inhibitor rotenone. Rotenone blocks the quinone binding site causing electrons 
to back up and fully reduce upstream redox centres (Brand 2010). ROS can also be 
produced by complex I from reverse electron transfer from complex II. Succinate 
reduces quinone through complex II. If membrane potential is high, this drives the 
electrons “back” to complex I generating a significant amount of ROS. This reaction 
can be blocked by rotenone since it inhibits this electron transfer. It can also be 
inhibited by reducing membrane potential. If membrane potential is low it is 
thermodynamically more favourable to transfer the electrons to complex III. This can 
be achieved by uncoupling the mitochondria with carbonylcyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) (Korshunov, Skulachev et al. 1997). 
Another site of ROS production is complex III. Complex III only produces superoxide 
at high rates when inhibited by antimycin A. Antimycin A is a Complex III inhibitor 
that blocks electron transfer from b hemes to quinone resulting in an increased 
formation of semiquinone at the complex III Qo –site, which in turn can transfer an 
electron to oxygen yielding superoxide (Brand 2010). In addition to being harmful, 
ROS may also perform vital signalling functions within the cell. Targets of these 
endogenous ROS signals are the redox-sensitive catalytic Cys residues of Tyr and 
MAPK phosphatases, the oxidation of which reversibly abolishes enzymatic activity 
(D'Autreaux and Toledano 2007). 
 
There seems to be an optimal redox range for the mitochondria to work within. Such 
that if the environment in the cell is too oxidized mitochondria produce little ROS but 
antioxidant systems function at a very low capacity. As the cell becomes more reduced 
mitochondria produce more ROS but antioxidant systems function at a much higher 
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level, leading to a decrease in ROS production. As the system becomes even more 
reduced antioxidant systems finally become overwhelmed and we again se a net 
increase in ROS (Aon, Cortassa et al. 2010). 
 
 
1.2 UNCOUPLING 
Uncoupling means that the primary proton pump (the electron transport chain) is 
uncoupled from the secondary proton pump, the ATP-synthase. This allows the 
electron transport chain to pump protons out of the mitochondrial matrix regardless of 
if the ATP-synthase is working (Nicholls and Ferguson 2002). 
 
1.2.1 Uncoupling proteins (UCPs) 
The UCPs are a subgroup of the mitochondrial protein carrier family. This family 
consist of 30 identified proteins. Mainly they transfer metabolites between the 
mitochondria and the cytoplasm. These proteins are all around 30 kDa and have two 
transmembrane domains. Some members of this family include the ATP/ADP 
translocator, the 2-oxoglutarate/malate and the citrate (tricarboxylate) carriers and 
UCPs. The first UCP found was uncoupling protein 1 (UCP1) reviewed in (Rousset, 
Alves-Guerra et al. 2004). UCP1 is exclusive to mammals. It is expressed in brown 
adipose tissue were it transports protons from the intermembrane space into the 
mitochondrial matrix without involving the ATP synthase. The main function of this 
process is to produce heat. Both UCP2 and UCP3 have 55% homology with UCP1 
while being 80% identical to each other. Whilst the function of UCP1 is well 
characterized, the function of the other UCPs is less clear.  
 
1.2.1.1 Uncoupling protein 2 
 
Many attempts to find the function of UCP2 have been based on its similarity to UCP1. 
However UCP2 does not seem to mediate thermogenic cold response (Nedergaard, 
Golozoubova et al. 2001) and the amount of UCP2 present in tissues calls into question 
if it is enough to mediate physiologically relevant uncoupling. Unlike UCP1, which is 
only expressed in brown adipose tissue UCP2 is expressed in many tissues. However 
UCP2 mRNA and protein expressions are not always correlated to each other 
(Pecqueur, Alves-Guerra et al. 2001). An explanation for this can be that UCP2 is 
regulated both on the transcriptional and translational level (Hurtaud, Gelly et al. 2006). 
This makes it likely UCP2 is involved in regulating rapid biological responses. Many 
phenotypes of the UCP2 KO mice could be interpreted as supporting the role for UCP2 
as an uncoupling protein. UCP2 negatively regulates glucose sensitive insulin secretion 
(GSIS), this was initially seen in the UCP2 knock out mouse which displayed a higher 
GSIS (Zhang, Baffy et al. 2001). This could be a result of increased coupling in beta 
cells lacking UCP2 leading to higher ATP production and thus more sensitive insulin 
release in response to glucose. UCP2 KO mice have higher ROS production in 
macrophages (Arsenijevic, Onuma et al. 2000; Emre, Hurtaud et al. 2007). If UCP2 is 
an uncoupling protein, lack of UCP2 could give rise to higher membrane potential and 
thus higher ROS production. UCP2 has shown some role in neuroprotection were 
overexpression reduces seizures (Diano, Matthews et al. 2003), decreases brain damage 
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after stroke (Mattiasson, Shamloo et al. 2003) and protects dopaminergic neurons 
(Andrews, Horvath et al. 2005). These effects also seem to be mediated by decreased 
ROS production. Trenker et al. have shown that UCP2 and UCP3 are important for 
Ca2+ regulation into the mitochondria. Ca2+ extrusion from mitochondria is dependent 
on membrane potential. Thus this would be a mechanism to uncouple the mitochondria 
albeit through a more complex route (Trenker, Malli et al. 2007).  
 
Another field of inquiry into UCP2 function is its ability to regulate substrate 
utilisation. UCP2 mRNA is upregulated in a variety of situations linked to increased 
fatty acids (Thompson and Kim 2004). UCP2 KO cells switch from fatty acid 
metabolism to glucose metabolism (Pecqueur, Bui et al. 2008). Another link to 
substrate utilization is glutamine, which can rapidly stimulate UCP2 translation 
(Hurtaud, Gelly et al. 2007). Since most of the family members in the mitochondrial 
carrier family transport metabolites between the mitochondria and the cytoplasm it has 
been proposed that many of the phenotypes seen in the UCP2 KO mice can be 
explained by a change in substrate utilisation, perhaps as a result of a transporting 
pyruvate out of the mitochondria (Bouillaud 2009).  
 
1.3 AGING 
Everyone feels they have an intuitive grasp of what aging is, but trying to define it is 
surprisingly difficult. There are several components to it. One is the age related increase 
in mortality rate. This is typically visualized by the Gompertz plot. In addition to the 
increase in mortality rate there is also functional decline and increased susceptibility to 
diseases that do not necessary result in death. There are several ways to define aging: 
 
- The process of becoming older.  
 
- The gradual changes in the structure and function of humans and animals that occur 
with the passage of time, that do not result from disease or other gross accidents, and 
that eventually lead to the increased probability of death as the person or animal 
grows older. 
 
- A progressive, generalized impairment of function, resulting in an increased 
vulnerability to environmental challenge and a growing risk of disease and death. 
 
Some of which are not useful for the purpose of this thesis. Biological aging is 
sometimes referred to as senescence in order to narrow the otherwise too broad 
meaning of the word. I choose to define aging as:  
 
-The gradual accumulation of deleterious changes for which the body becomes 
progressively worse at compensating for or repairing resulting in an increased risk of 
death over time. 
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1.3.1 Evolutionary views on aging 
Aging was first viewed as wear and tear. Just as inanimate objects wear out, so do 
living beings. This is superficially true. But living systems have an advantage over 
inanimate objects; by the influx of energy living systems are able to repair themselves 
and maintain their integrity. In essence, living systems are immortal by the fact that 
they can reproduce. Even if individual members of a species die the germline is 
immortal. Also it is evident that different species have different life spans and are able 
to fend of decline more or less effectively. Clearly there is a benefit to maintaining the 
body for a certain amount of time but is it sufficiently beneficial to attempt to do so 
indefinitely as with the germline? Are there other forces at play which antagonize this 
process?  
 
The first thing to note is that the force of natural selection decreases over time. All 
animals have a certain statistical risk of dying despite the aging process. For animals 
that have many natural enemies they are statistically very likely dead before the 
deleterious effects of aging sets in. Thus there is very little that natural selection can act 
upon to slow aging. Indeed these animals are generally more short-lived.  
 
 In 1957 Williams (Williams 1957) proposed that genes which have a selective 
advantage early in life will be selected for even if the late life effects of these genes are 
deleterious. This might cause unbeneficial phenotypes late in life and thus aging. This 
theory is called antagonistic pleiotropy.  
 
The production of long lived fruit flies by delaying the age of reproduction has revealed 
that it is relatively simple for natural selection to extend both lifespan and health span 
(Rose and Graves 1989). Rose (Rose 2009) argues that aging is due to the inability of 
the organism to sustain adaptation and thus health late in life. However if circumstances 
change making longer life and health a significant benefit, natural selection can adapt 
an organism to good health at any age.  
 
Thomas Kirkwood proposed the disposable soma theory in 1977 (Kirkwood 1977). The 
main idea here is that the body has limited resources. With a finite amount of food not 
all processes can be optimized. It does not make sense for the body to allocate an 
inordinate amount of resources on maintaining a body that will likely only be used for a 
short amount of time. 
 
Evolutionary theories of aging help inform us as to what to look for on the level of the 
organism. If aging is a simple program that is selected for we might expect to find non-
aging mutants that have a disrupted aging program. Since we have not encountered any, 
this scenario does not seem very likely. Also there does not seem to be some intrinsic 
factor causing aging that natural selection cannot compensate for. Instead what we see 
in nature is that natural selection seems to be able to shift the lifespan of species with 
wildly different life styles toward a lifespan that makes sense in regard to current 
evolutionary pressures. 
 
  8 
1.3.2 Cellular senescence 
Most mammalian cells do not divide indefinitely. This was not always thought to be the 
case. In the dawn of cell culture research a French physician named Alexis Carrel was 
able grow cells from an embryonic chicken heart for over 20 years. This lead to the 
idea that cells could divide indefinitely if they were just given the right conditions. 
These experiments were however impossible to replicate outside of Carrels lab. Likely 
the serum used for the cell culture was not cell free and so new cells were added every 
time the media was exchanged.  
 
In the 1960s Leonard Hayflick noticed that human fibroblasts predictably stop dividing 
after 40-60 population doublings (Hayflick and Moorhead 1961). To be sure of their 
results Hayflick and Moorhead sent their samples to several outside labs and asked 
them to give them a call when the cells stopped dividing. As expected, after 6 months 
the calls started dropping in. All of the cultures had stopped dividing and Hayflick and 
Moorehead were now sufficiently confident in their finding to publish the results. There 
seemed to be a counting mechanism that decided how many times the cells were able to 
divide. This counting mechanism was later found to be the telomeres (Yu, Bradley et 
al. 1990). Telomeres are the protective cap at the end of the chromosomes that gets 
shorter with each cell division. Cells can senesce when the telomeres are sufficiently 
deteriorated or when damage to other parts of the DNA invokes the DNA damage 
response (DDR). The DDR can either induce repair, apoptosis or senescence. Cells can 
also senesce through other stressors when they are grown in cell culture, such as serum, 
high oxygen tension or even cell plastic (Sherr and DePinho 2000). 
 
What defines a senescent cell? Senescent cells cannot continue dividing, this is 
however not the same as a terminally differentiated cell. Senescent cells are bloated and 
swell up, sometimes to twice their size. On the chromatin level, cellular senescence is 
associated with a condensation of chromatin called senescence associated 
heterochromatic foci (SAHFs). The cells containing SAHFs also loose histone H1 
(Funayama, Saito et al. 2006). In addition to morphological changes senescent cells 
have some additional defining characteristics. An important feature is their resistance to 
apoptosis (Wang 1995). The main biomarker of senescent cells is the activity of β-
galactosidase at pH 6.0 which is normally only active at ph 4.0 (Dimri, Lee et al. 1995). 
This marker increases in both aging cell cultures and aging in vivo. Senescent cells 
generally express P16INK4, a tumor suppressor that increases with age in both mice and 
humans.  
 
Why does cellular senescence exist? There are strong arguments to be made that 
cellular senescence is a protective mechanism against cancer. Essentially all tumors 
have a mechanism for maintaining telomere length. Mice deficient for telomerase are 
protected against tumor formation (Feldser and Greider 2007). In many cases senescent 
cells have been found in pre malignant tumors suggesting that cellular senescence can 
restrict tumor progression, reviewed in (Collado, Blasco et al. 2007). 
 
It is not clear if or in what way cellular senescence is important for organismal aging. 
More senescent cells are found in older individuals compared to younger (Jeyapalan, 
Ferreira et al. 2007; Rodier and Campisi 2011). If cellular senescence is important in 
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vivo, it might be expected that cells from older individuals would undergo fewer 
population doubling than cells from younger individuals when grown in culture. 
However the evidence for this is ambiguous. Some studies indeed find that cells from 
older individuals have lower replicative capacity (Kaji, Ohta et al. 2009), whereas 
others have found only weak (Smith, Venable et al. 2002) or no correlation (Cristofalo, 
Allen et al. 1998). One problem with these types of studies is that they only select for 
cells that have replicative capacity. Even if old people have some cells that still have 
full replicative capacity the cells that cannot continue replication might pose a problem. 
One way senescent cells could contribute to organismal aging is due to a decrease in 
vital stem cell pools since senescent cells cannot divide and also not perform their 
initial function. Another way these cells can be detrimental is through their influence on 
other cells. Senescent cells secrete proinflammatory cytokines, this is called senescence 
associated secretory phenotype (SASP) (Campisi 2005). Older individuals have 
increased levels of proinflammatory cytokines such as IL-6 and TNF- α. These may 
contribute to chronic inflammation, which is associated with many age related diseases 
such as Alzheimers disease, osteoarthritis and diabetes. It has been observed that 
individuals who “age well” have a lower inflammatory profile (Franceschi, Capri et al. 
2007). If these mechanisms are indeed important for organismal aging it can be seen as 
antagonistic pleiotropy. The mechanism that inhibits cancer growth early and 
throughout an individual’s life does so at the cost of decreasing its fitness later when it 
is not as “visible” to the forces of natural selection. 
 
1.3.3 Aging theories 
There are many aging theories, which approach the phenomena from different angles. 
Damage is the common denominator of several aging theories. Organisms are 
constantly subjected to damage and have different ways of coping with it. Some 
damage is especially hard to deal with. One such type of damage is mutations. Since 
the DNA is the template from which the cell is built. Another form of DNA damage is 
damage to telomeres. Since nuclear DNA does not have the privilege of being circular 
like mitochondrial DNA, the end of the chromosome is not copied during DNA 
replication. To get around this issue the tips of the chromosomes are capped with 
TTAGGG repeats which are the DNA part of the telomeres. These get shorter for each 
round of replication but can be extended if the enzyme telomerase is activated.  
Telomeres have been an interesting candidate for causing aging since it was discovered 
that they limit the amount of times a cell can divide (Yu, Bradley et al. 1990). It 
remains unclear however how important this is for pathology and how many cells 
actually reach the point were they are inhibited by lack of adequate telomere length. 
Since mice have longer telomeres than humans it was thought that telomere length 
would not limit mouse life span since their telomeres would not become short enough 
to compromise chromosome integrity. A study overexpressing telomerase in cancer 
resistant mice (Tomas-Loba, Flores et al. 2008) shows that although mice have longer 
telomeres than humans, increasing their telomere length also increased their lifespan. 
Recently Jaskelioff, et al. (Jaskelioff, Muller et al. 2011) reintroduced telomerase into 
telomerase deficient mice and found that many of the premature aging phenotypes were 
reversed upon telomerase reactivation. In addition to being shortened at every cell 
division due to the polymerases inability to replicate the first bases, telomeres can also 
  10 
be damaged by oxidative stress. This may in fact be the major cause of telomere 
shortening (Passos, Saretzki et al. 2007). 
 
In addition to DNA damage waste accumulation can be problematic. Not all molecular 
damage will be repaired or degraded by the cell. Over time “garbage” builds up inside 
and outside the cell. In lysosomes this is easily visible as a pigment called lipofuscin. 
This is mainly found in non-dividing cells such as cardiomyocytes and neurons. These 
lipofuscin-loaded lysosomes perform poorly and cannot remove modified proteins, 
altered biomembranes, defective mitochondria and other organelles. This has been 
proposed to cause accumulation of defective mitochondria with increased ROS 
production (Terman and Brunk 2006).  
 
The most widely accepted of all damage theories is the free radical and mitochondrial 
theory of aging, which will be discussed, in the next chapter. 
 
1.3.4 Mitochondria and Aging 
Mitochondria were first implicated in the aging process when it was discovered that 
they produce ROS as a by-product of respiration. Evidence from many paths of 
gerontological research suggests that mitochondria are one of the key players in aging. 
Several age-related changes occur in mitochondria. The number of mitochondria 
decreases in post-mitotic tissues like heart, skeletal muscle and brain during aging 
(Samorajski, Friede et al. 1971; Herbener 1976). Structural changes such as alterations 
of cristae structure, matrix vacuolization or densification and enlargement of 
mitochondria have been found to increase with age (Wilson and Franks 1975; Wilson 
and Franks 1975). Mitochondrial DNA (mtDNA) point mutations and deletions have 
been detected in aging humans, and have, in many cases been correlated to 
mitochondrial dysfunction. Deletions in mtDNA are found in postmitotic tissues e.g., 
skeletal muscle, heart and brain in contrast to kidney, spleen, skin and liver that are 
composed of dividing cells, indicating a tissue-specific "pattern" of deletion 
accumulation (Cortopassi, Shibata et al. 1992). The level of deletions is however 
usually very low (under 1% of deleted mtDNA in whole tissue homogenate) (Wallace 
2005). This calls into question if they have a causative effect or if they are only 
correlated with aging. In mitochondrial diseases a threshold level needs to be reached 
before point mutations or deletions cause pathology. In dopaminergic neurons mtDNA 
deletions are related to Parkinson’s disease when they reach a level of around 52% 
(Bender, Krishnan et al. 2006). The same is true for point mutations. The threshold 
level varies depending on the point mutation but generally they need to reach a level of 
90% before causing pathology (Trifunovic and Larsson 2008). However, point 
mutations can clonally expand and cause deficiency in single cells or a part of the 
tissue. For instance, analysis of mtDNA point mutations in five tRNA genes showed 
high levels of clonally expanded mtDNA point mutations (49%-94%) in COX-deficient 
skeletal muscle fibers isolated from aged individuals (Fayet, Jansson et al. 2002). Also, 
when stem cells in colonic crypts divide, mtDNA with point mutations can be unevenly 
distributed causing all the cells stemming from the crypt to have deficient respiration 
(Taylor, Barron et al. 2003).  
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Mitochondria are a key regulator for apoptosis through several pathways (Mayer and 
Oberbauer 2003). For example cytochrome c release from the mitochondria into the 
cytosol where it recruits adaptor proteins and initiates caspase signalling leading to 
apoptosis (Liu, Kim et al. 1996). There is evidence that mitochondrial dysfunction can 
cause an increase in apoptosis (Niu, Trifunovic et al. 2007). This might lead to the loss  
of critical cells, causing aging or premature aging phenotypes. 
 
One of the first to implicate mitochondria in the aging process was Denham Harman 
(Harman 1972; Harman 1972). The theory attributes aging to damage caused by 
reactive oxygen species (ROS). Mitochondria produce ROS by the process of 
respiration in the electron transport chain. In addition, mitochondria are the only 
organelle that contain their own DNA, which is in close proximity to where ROS are 
produced. Potentially ROS could damage the mtDNA causing mutations, thereby 
leading to irreversible damage for the organelle. The vicious cycle hypothesis states 
that ROS causing damage to the mtDNA leads to mutations that in turn lead to faulty 
production of respiratory chain subunits for which the mtDNA encodes. This causes the 
respiratory chain, harbouring these faulty respiratory chain subunits, to produce more 
ROS. This cycle feeds on itself causing an ever-increasing speed of decline. The idea 
that ROS production would increase when respiratory chain subunits are damaged is 
true for certain mutations. An example of this is found in fibroblasts from patients 
presenting an isolated complex V deficiency due to mutation in ATPase 6 gene 
(Geromel, Kadhom et al. 2001; Baracca, Sgarbi et al. 2007). Studies of fibroblasts from 
patients suffering isolated complex I deficiency have shown both increase in ROS 
production (Iuso, Scacco et al. 2006) but also no increased ROS levels in fibroblasts 
with mutations in the NDUFA1 and NDUFV1 genes (Moran, Rivera et al. 2010). 
mtDNA mutations can cause increase in ROS production but it is not clear how 
common this is and if it is a significant contributor to the aging process.  
 
A correlative link between ROS production and the aging process comes from a 
comparison between species longevity and the amount of ROS that is produced from 
isolated mitochondria (Ku, Brunk et al. 1993). They showed that longer-lived species 
produce less ROS from isolated mitochondria. Interestingly there is an inverse 
relationship between the level of antioxidant enzymes and longevity (Barja, Cadenas et 
al. 1994). This argues that if ROS damage is a cause of aging, low ROS production is 
more important in order to limit ROS damage than is antioxidant enzyme systems.   
In caloric restriction, an intervention that increases the lifespan of a range of animals, 
ROS production is reduced (Gredilla, Sanz et al. 2001). An alternative explanation 
could be that another aspect of mitochondrial function is selected for in long-lived 
species, which also decreases ROS production. If lower net ROS levels were not 
important for species longevity, then lower levels of antioxidant enzymes would be 
expected.  
 
Studies overexpressing antioxidant enzymes have yielded conflicting results. 
Overexpressing copper zinc superoxide dismutase (CuZnSOD), catalase, or 
combinations of either CuZnSOD and catalase or CuZnSOD and manganese 
superoxide dismutase (MnSOD) does not increase the lifespan of mice (Perez, Van 
Remmen et al. 2009). However mice overexpressing catalase targeted to mitochondria 
  12 
have a 20% increase in median lifespan and a 10% increase in maximum lifespan 
(Schriner, Linford et al. 2005).  
 
Other studies have studies could be interpreted as mitochondrial ROS promoting 
longevity.  Mice that are heterozygous for Mclk, a mitochondrial enzyme that is 
necessary for ubiquinone biosynthesis, (Liu, Jiang et al. 2005) (Lapointe and Hekimi 
2008) have mitochondrial dysfunction with more oxidative damage in the mitochondria 
and less oxidative damage in cytosolic proteins. These mice also have increased 
lifespan despite having increased oxidative damage to mitochondria.  
 
Many mutations that effect lifespan, as well as the most robust non-genetic 
intervention, caloric restriction, are linked to the insulin signalling pathway (Kenyon 
2011). This pathway intersects with mitochondrial function at several junctions. In 
C.elegans the insulin/insulin like growth factor receptor is encoded by daf-2. This was 
one of the first longevity genes found. Daf-2 mutants have decreased insulin signalling 
and prolonged lifespan. This is accompanied by increased mitochondrial function 
higher membrane potential and higher ROS production but decreased oxidative stress 
in the form of protein carbonyls (Brys, Castelein et al. 2010). ISP-1 encodes a complex 
III subunit in C.elegans. ISP-1 mutants have increased superoxide production and 
longevity. Interestingly the effect on lifespan can be attenuated by antioxidants (Yang 
and Hekimi 2010).  
 
Another possible link to the effect of mitochondria on the aging process comes from 
sirtuins. Sirtuins are NADH dependent deacetylases. It has been proposed that the 
effects of calorie restriction, a method of increasing lifespan in a variety of animals, are 
mediated by the SIR2 gene family that have been shown to extend lifespan in 
C.elegans, yeast and Drosophila (Donmez and Guarente 2010). SIRT1 a mammalian 
member of the SIR2 gene family targets PGC1α, which mediates mitochondrial 
biogenesis (Lagouge, Argmann et al. 2006).  
 
Studies in mice that accumulate mutations in mtDNA (mtDNA mutator mice) (the mice 
which are the focus of this thesis) (Trifunovic, Wredenberg et al. 2004) argue against 
the vicious cycle hypothesis. Even though these mice have a large amount of point 
mutations they do not have increased ROS production (Trifunovic, Hansson et al. 
2005). Rather it seems as if most point mutations cause the respiratory chain subunits to 
degrade (Edgar, Shabalina et al. 2009), causing decreased respiration but not increased 
ROS production. Still it is not inconceivable that ROS generating point mutations play 
a role in the aging process.  
 
The role of mitochondria in normal aging is still unclear. Though it seems that some 
aspects of mitochondrial function are linked to longevity. Even though mtDNA 
mutations accumulate with age and mitochondrial function declines, we do not in 
normal aging accumulate the same levels of point mutations as the mtDNA mutator 
mice do. However mtDNA mutations can certainly cause aging phenotypes if present at 
sufficient levels and mitochondrial dysfunction can drive age related pathology. The 
fact that pathways associated with aging seem to affect and be affected by 
mitochondria, make them an attractive candidate for many of the pathological changes 
seen in aging. While it is obvious that very high levels of ROS are pathological, a 
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moderate increase in ROS is in some cases related to increased lifespan. One possible 
mechanism for this is hormesis. This is the notion that a small amount of a toxin, like 
ROS may promote a general stress resistance to ROS or even other stressors. Another 
possibility is that there are other aspects of mitochondrial function that are important 
for the aging process and that the effects on ROS are secondary to this. It might be 
fruitful to investigate if there are any common elements of mitochondrial function in 
different models were both aging and mitochondria are affected. 
 
1.4 THE mtDNA MUTATOR MOUSE 
To test the causative role of mtDNA mutations in aging, the mtDNA mutator mouse 
was developed. The mtDNA mutator mouse accumulates high levels of point 
mutations due to a proofreading deficiency of the mitochondrial DNA polymerase 
(POLG) (Trifunovic, Wredenberg et al. 2004). The estimated number of point 
mutations in the heart of 25-week-old mtDNA mutator mice is 14 mutations per 
10.000 base pairs. The mice are born in Mendelian proportions, without any visible 
defects, but after 6-7 months they start to display a range of premature aging 
phenotypes, such as a weight loss, reduced subcutaneous fat, alopecia, kyphosis, 
osteoporosis, anemia, reduced fertility, heart disease, sarcopenia, progressive hearing 
loss and decreased spontaneous activity (Trifunovic, Wredenberg et al. 2004; Niu, 
Trifunovic et al. 2007). Their lifespan is also greatly reduced compared with wild-
type littermate controls and they die at around 46 weeks of age. In addition to the 
standard circular chromosome, mtDNA mutator mice harbour large linear mtDNA 
molecules caused by replication stalling (Bailey, Cluett et al. 2009). These molecules 
are around 11-12 kb in length, and encompass the region between the origins of 
replication for the heavy (OH) and the light strands (OL). Around 25-30% of the 
mtDNA consists of these linear molecules with deletion, and this ratio does not change 
as the animals age (Trifunovic, Wredenberg et al. 2004). As these molecules exist at 
quite high levels, it has been proposed that this may also contribute to the progeroid 
phenotype of the mtDNA mutator mouse (Trifunovic, Wredenberg et al. 2004; Bailey, 
Cluett et al. 2009). The POLG exonuclease activity may be involved in the resolution 
of replication intermediates at OL, which can explain why exonuclease deficiency will 
lead to replication stalling, thus leaving the mtDNA molecule susceptible to breakage at 
the stall site (Bailey, Cluett et al. 2009). It has also been suggested that the time needed 
for the replication of mtDNA could be prolonged in the mtDNA mutator mouse, as 
evidenced by a high amount of replication intermediates (Bailey, Cluett et al. 2009). 
This prolonged replication is proposed to exhaust resources in the mitochondria. 
Although plausible, this hypothesis still requires direct experimental verification. One 
observation from the mtDNA mutator mice is that amino acid changing mutations in 
the protein coding genes are very poorly tolerated. Most mutations in the first and 
third codon positions disappear after only a few generations of backcrossing mtDNA 
mutator females to wt, whereas tRNA mutations do not seem to be strongly selected 
against (Stewart, Freyer et al. 2008). 
 
One consequence of the compromised mitochondria is increased apoptosis. This was 
found in a study looking at progressive hearing loss in the spiral ganglion in the 
mutator mouse (Niu, Trifunovic et al. 2007) and a in a range of other tissues in a 
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similar mouse model (Hiona, Sanz et al. ; Kujoth, Hiona et al. 2005) including 
thymus, intestine, testis and muscle.  
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2 SPECIFIC AIMS 
Paper I: To investigate how a defective polymerase causes mitochondrial dysfunction 
and premature aging phenotypes in the mtDNA mutator mice. More specifically, to 
examine weather point mutations or circular deletions are the driving force and to 
determine at what stage the mutations are causing a problem for the mitochondria i.e. 
transcription, translation or assembly. 
 
Paper II: To examine how ROS production and oxidative stress is affected by having a 
large amount of mutations in the mitochondrial DNA. More specifically, to examine 
the sources of ROS production and the amount of ROS produced from forward and 
reverse electron transfer. As well as examining the amount and type of ROS damage 
produced.  
 
Paper III: To examine the effect of mtDNA mutations on cell proliferation in vitro, 
more specifically, to investigate cellular senescence and immortalization of MEFs 
under various conditions. Also examining the pathways the cells take to 
immortalization or senescence. 
 
Paper IV: To investigate the effect of UCP2 ablation in mtDNA mutator mice. 
Characterizing the bioenergetics of mtDNA mutator mice with and without UCP2. 
Also, looking at the phenotypic effects of UCP2 ablation in mtDNA mutator mice.  
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3 RESULTS AND DISCUSSION 
 
3.1 ON POINT MUTATIONS AND CIRCULAR MOLECULES WITH LARGE 
DELETIONS 
In paper I (Edgar, Shabalina et al. 2009) we state that point mutations are the driving 
force behind the progeroid phenotypes in the mtDNA mutator mice. We found that 
mtDNA mutator mitochondria have lower respiratory capacity compared to wt. We 
also directly measured the capacity of the electron transport chain by permeabilizing 
mitochondria with alameticin and feeding NADH directly into complex I, and found 
that it was reduced. With BN-PAGE we measured a reduction in the level of assembled 
complex for complex I, III, and IV. Reduction in complex levels could in principle be 
the result of impaired transcription, translation or assembly/protein stability. We 
measured steady state levels of RNA with northern blot. There was no general 
reduction in mitochondrial RNA levels, rather an up regulation of some transcripts. We 
directly measured protein synthesis from mitochondria by an in organello translation 
assay. Protein synthesis was normal, but after a 3h and 5h chase with cold methionine 
we found rapid breakdown of the mitochondrially transcribed proteins. We believe the 
best explanation for this is that point mutations that cause amino acid substitutions lead 
to the increased turnover in these defective subunits.  
 
Another group has published a paper with a similar mouse model claiming it was 
circular molecules with deletions that were the main driving force behind the premature 
aging phenotype.  
 
Our finding that the dysfunction of the mitochondria was driven mainly by inability to 
assemble the complexes led us also to directly examine if we could detect circular 
molecules with deletions. We concluded that if they did exist the levels were very low 
and were unlikely the cause of the phenotype (Edgar, Shabalina et al. 2009). Our results 
were questioned by another group, who had previously claimed that it was these 
circular molecules with deletions that were the main driving force behind the premature 
aging phenotypes (Vermulst, Wanagat et al. 2008). This triggered a heated scientific 
discussion (Vermulst, Wanagat et al. 2009), (Edgar, Larsson et al. 2009) and (Edgar 
and Trifunovic 2009), that will be discussed in more detail below. 
 
There has also been some discrepancy in the amount of point mutations found in the 
different mouse models and genotypes (hz, wt and mut POLG). These discrepancies are 
confusing and can lead to very different interpretations of the data. This following 
section attempts to clarify some issues regarding detection of point mutations and 
circular molecules with large deletions. I will first address the discrepancy in point 
mutations and then go on to the question of what type of mutations are most likely to 
cause the premature aging phenotype:  
  17 
 
 
Genotype Brain ~8 weeks Heart ~25 weeks 
WT 0,33 (CS) (Trifunovic, Wredenberg et al. 
2004) 
0,0066 (RMC) (Vermulst, Bielas et al. 2007) 
4,58 (CS) (Trifunovic, Wredenberg et al. 
2004) 
2,11 (CS) (Kujoth, Hiona et al. 2005) 
HZ 1,33 (CS) (Trifunovic, Wredenberg et al. 
2004) 
3,3 (RMC) (Vermulst, Bielas et al. 2007) 
- 
 
- 
MUT 9 (CS) (Trifunovic, Wredenberg et al. 2004) 
14 (RMC) (Vermulst, Bielas et al. 2007) 
14 (CS) (Trifunovic, Wredenberg et al. 
2004) 
10 (CS) (Kujoth, Hiona et al. 2005) 
Table 1. The number of mtDNA point mutations/10000 base pairs detected by different groups using the 
CS and RMC approaches. 
 
Different approaches have been tried to measure levels of somatic mtDNA mutations 
and the results often vary considerably depending on the method used, e.g. cloning-
sequencing (CS) or random mutation capture (RMC) (Table 1). Both of these methods 
seem to detect comparable differences in levels of mutations in mice heterozygous 
(POLG+/mut) or homozygous (POLGmut/mut) for the mtDNA mutator allele. However, the 
RMC method detects a 500-fold less mtDNA mutation load in control mice, i.e. wild 
type animals obtained after intercrossing mice heterozygous for the mtDNA mutator 
allele (Table 1). The CS method is the most frequently used procedure to estimate the 
level of mtDNA mutations and involves PCR amplification of mtDNA, followed by 
cloning and sequencing of the obtained fragment. A problem with this method is that 
PCR might introduce mutations in the initial step, which are then carried through to the 
sequencing reaction. The RMC was developed by Vermulst et al. (Vermulst, Bielas et 
al. 2007) and is based on the fact that mtDNA mutations will alter a given restriction 
enzyme recognition site. After restriction enzyme digestion only mutated molecules 
should be amplified by PCR and those are subsequently quantified and sequenced. 
However, the target sequence analyzed by this method is only 4 bases long (Taq I 
recognition site) and may therefore not represent the prevalence of mutations over the 
entire molecule (Vermulst, Bielas et al. 2007). The RMC assay appears to work very 
well on large sample sizes when the mutations are evenly distributed throughout the 
genome (Kraytsberg, Simon et al. 2009). However, when existing mutations affect few 
sites but have been amplified, they might be missed. mtDNA mutations can clonally 
expand in certain tissues, i.e. when a stem cell gives rise to many cells. This can also 
happen randomly when mtDNA molecules are segregated or replicated unevenly. In 
human colonic mucosa (a tissue known to clonally expand mtDNA mutations) the 
RMC routinely detects between 10-1000 times less mutations than the CS approach and 
around 5 times less than with single-molecule-PCR based method (Kraytsberg, Simon 
et al. 2009). 
 
The analysis of mtDNA mutation load in wild-type animals will be complicated when 
the animals are derived from a mother heterozygous for the mtDNA mutator allele. The 
reason is that the primordial germ cells of a heterozygous mother contain one copy of 
the mutant POLG allele and this could cause accumulation of a small amount of 
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mtDNA mutations during their proliferation and maturation into oocytes. A genetic 
bottleneck occurs after the oocyte is fertilized whereby a small subset of all mtDNA 
molecules are partitioned into the primordial germ cells of the next generation 
(Hauswirth and Laipis 1982). Subsequent rounds of replication in the wt embryo are 
then carried out by only wt POLG, whereas in the mtDNA mutator embryo 
proofreading-deficient POLG is used. As a result, the embryo with the mutator allele 
will continue to introduce new mutations, whereas the wt embryo will amplify only the 
pre-existing mutations with high fidelity. This could explain why wt littermates of 
mtDNA mutator mice may have a moderately increased mutation load in comparison 
with other wild-type mice whose mitochondria have never come in contact with the 
mtDNA mutator allele. Heterozygous animals from the same cross might continue to 
accumulate random mtDNA mutations, but to a much lesser extent than mtDNA 
mutator mice. The pedigree of the analyzed wild-type mice is therefore an important 
factor to consider when determining mtDNA mutation loads. In order to resolve this 
issue, we believe that a direct cloning and sequencing approach should be used. This 
would involve the cloning of large fragments or an entire mtDNA molecule into a 
vector, without the use of an intermediate PCR step (Battey and Clayton 1978). In this 
way PCR- induced errors will be avoided and a more complete picture of the 
distribution of mutations on the population of mtDNA molecules will be achieved. 
Direct cloning and sequencing has three major drawbacks. First, it is labour intensive. 
Second, it would require a large sequencing effort to sample the same magnitude of 
bases as a RMC assay, making sequencing costs prohibitive. Finally, cloning of small 
amounts of sample DNA is often inefficient and studying single cells is therefore not 
possible at the moment. Alternatively, the cloning step could be circumvented by usage 
of newly developed deep sequencing techniques that could be quantitative simply 
because the same region of the mtDNA would be sequenced over and over again. 
However, many deep sequencing methods have inherent error rates, which may 
obscure somatic mtDNA mutation loads. 
 
In a recently published paper, Loeb and co-workers suggest that a third type of mtDNA 
mutation, besides the very abundant point mutations and linear deletions we have 
reported (Trifunovic, Wredenberg et al. 2004), are the main driving force behind the 
shortened lifespan in mtDNA mutator mice (Vermulst, Wanagat et al. 2008). This third 
type of mutation is circular mtDNA molecule with large deletions of several thousand 
base pairs. The main argument for this conclusion is that the RMC method detects a 
500-fold increase of mtDNA point mutations in heterozygous, POLG+/mut in comparison 
with wild-type mice, despite the fact the heterozygous mice have a normal lifespan 
(Vermulst, Bielas et al. 2007). The authors also reported that circular mtDNA 
molecules with deletions are highly increased in frequency throughout the lifetime of 
the mtDNA mutator mouse. Similar molecules are also found to accumulate in the wt 
and POLG+/mut mice, but to a much lesser extent (10- 100 times lower). In light of this 
evidence they conclude that the circular mtDNA molecules with deletions correlate 
much better with the phenotype and therefore must be the driving force behind the 
premature aging of mtDNA mutator mice (Vermulst, Wanagat et al. 2008). However, 
their study is purely correlative and it does not take into account threshold levels that 
are the imperative in mitochondrial genetics. In their study, they have estimated only 
the relative amount of circular mtDNA molecules with deletions between genotypes. 
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To estimate the importance of these circular mtDNA molecules with deletions it is 
necessary to know what fraction of the total mtDNA they represent.  
 
We attempted to detect the circular molecules with deletions using long extension PCR 
technique. As controls, we used two strains of mice with known amounts of deletions, 
the mito-mouse and the deletor mouse (Sato, Kono et al. 2005; Tyynismaa, Mjosund et 
al. 2005). These mouse strains carry circular mtDNA molecules with single (mito-
mice) or multiple (deletor-mice) deletions in their mitochondria. Although we have 
robustly detected deleted mtDNA molecules in serial dilutions of these control samples 
we did not detect any deletions in mtDNA mutator heart or liver samples. Recently, 
Kraytsberg et. al used single molecule long extension PCR to detect deletions in 
mtDNA mutator samples provided by Loeb and co-workers (Kraytsberg, Simon et al. 
2009). They did not detect deleted mtDNA among more than 320 amplified molecules 
from duodenum and 144 molecules from heart of mtDNA mutator mice (Kraytsberg, 
Simon et al. 2009). This completely agrees with our data obtained from heart and liver 
of mtDNA mutator mice. Kraytsberg et. al detected some mtDNA deletions in brain 
tissue, but estimated the relative levels to be around 1% and they argue that this could 
be an overestimation (Kraytsberg, Simon et al. 2009). 
 
It is unclear how these rare circular molecules with deletions could be the major driving 
force behind the shortened lifespan in the mutator mice. The mito-mice with deletions 
in up to 30% of all mtDNA molecules do not die early, whereas those with deletions in 
70% suffer from renal failure (Sato, Kono et al. 2005). The deletor mouse, although 
generating multiple deletions of the same range as proposed for mtDNA mutator mice, 
show no premature aging phenotype. The deletor mice have normal lifespan but 
develop mitochondrial myopathy late in life (Tyynismaa, Mjosund et al. 2005). 
Furthermore, deletions are not related to Parkinson’s disease until they reach a 
threshold of around 52% in dopaminergic neurons of humans (Bender, Krishnan et al. 
2006). The same is true for most diseases caused by mutations in mtDNA. There is 
always a threshold level of mutation that has to be reached before the mutation causes 
respiratory chain dysfunction. This threshold level will vary depending on mutation, 
but is generally between 60% (for deletions) - 90% (point mutations) (Trifunovic and 
Larsson 2008). In the mtDNA mutator mouse the mutations are spread out over the 
genome and a very high threshold level of a particular mutation might not be reached. 
However, if every molecule accumulates approximately 20 mutations, many of these 
will be in protein coding genes. For COXI for example there would be an 88% chance 
that the gene contains at least 1 mutation in a specific mtDNA molecule and a 61% 
chance that it contains at least 2 mutations of which 40% will cause amino acid change 
(and we know these mutations in mtDNA are very poorly tolerated). Then there are 
another 12 genes for which numbers are slightly different depending on the size of the 
genes. Assuming random distribution of the mutations, a threshold level will be 
reached easily, not by one specific mutation, but by the sum of all different mutations. 
Deletions, though affecting many base pairs, still need to be at significant levels to 
cause mitochondrial dysfunction. It has been estimated that there is about 1000 point 
mutations for every single deleted mtDNA molecule in mtDNA mutator mice (if there 
is >0.02 deletion per mtDNA molecule) (Kraytsberg, Simon et al. 2009). This also 
means that mtDNA mutator mice have about 800 additional point mutations for every 
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additional deletion when compared to POLG+/mut animals (Kraytsberg, Simon et al. 
2009). 
 
Loeb and co-workers do not report increased amounts of deletions in COX-negative 
cells (cytochrome c oxidase deficient cells – indicating mitochondrial dysfunction), 
only an increase in point mutations (Vermulst, Wanagat et al. 2008).  
 
Large circular mtDNA deletions typically span over several protein coding genes and 
include a number of tRNA genes. Therefore, consequences of the large deletions could 
be detected as a reduction in mitochondrial transcript levels or as a decrease in 
translation of mitochondrially-encoded proteins if present at high levels (it is true that 
this might not be detected if these deletions are few and random but then the question 
of how they would cause pathology remains). This, however, does not seem to be the 
case. We found that the pattern of transcriptional change was more consistent with 
increased activity from the heavy strand promoter, rather than a loss of components via 
deletions. Translation was also normal, but we did observe increased protein turnover 
(Edgar, Shabalina et al. 2009). So the mechanism by which these rare, circular mtDNA 
molecules with deletions would be causing the premature aging phenotype remains 
unclear. We might not have conclusively proven that the point mutations are the cause 
of the premature aging phenotype, however I have tried to make the case that this is the 
most plausible explanation.  
 
Finally the question of weather the mutator mice can be regarded as a model for normal 
aging. It is not normal aging, however it does answer several long-standing questions in 
the field of aging research. Mitochondrial dysfunction, as is seen in normal aging, can 
be the cause of many aging phenotypes. Mitochondrial mutations in protein coding 
genes are very poorly tolerated, often causing respiratory chain complexes not be 
assembled and they are strongly selected against. Also a large amount of mtDNA 
mutations does not seem to produce a vicious cycle of increasing amounts of ROS, but 
this will be discussed in more detail in the next chapter.  
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3.2 ON REACTIVE OXYGEN SPECIES AND OXIDATIVE STRESS IN 
MTDNA MUTATOR MICE 
The vicious cycle hypothesis predicts that increasing point mutations in mtDNA would 
cause increased ROS production. This was not found in the mtDNA mutator mouse as 
measured in mouse embryonic fibroblast (Trifunovic, Hansson et al. 2005) and in 
isolated mitochondria (paper II). In paper II we see that ROS production changes in 
different directions depending on were what substrate is used. If mitochondria are 
energized by succinate mtDNA mutator mitochondria produce much less ROS than wt 
mitochondria. However if the electron transport chain is initiated at complex I with 
pyruvate or glutamate, mtDNA mutator mitochondria produce slightly more ROS. On a 
combination of complex I and complex II substrates, allowing mitochondria to work at 
their maximum capacity (Gnaiger 2009) maximum ROS production is substantially 
reduced in mtDNA mitochondria compared to wt mitochondria. This difference in ROS 
production between the genotypes is mainly a consequence of reversed electron 
transfer. This can be determined by the effect on ROS production by rotenone. 
Rotenone is a complex I inhibitor which increases ROS production from forward 
electron transfer but inhibits reverse electron transfer (Brand 2010). Succinate reduces 
quinone through complex II. If membrane potential is high, this drives the electrons 
“back” to complex I generating a lot of ROS. If membrane potential is low it is 
thermodynamically more favourable to transfer the electrons to complex III. It is not 
clear how much reverse electron transfer contributes to ROS production in vivo (Brand 
2010). In many cases supraphysiological levels of succinate are needed to achieve 
reverse electron flow when mitochondria are respiring on succinate alone. Steady state 
concentrations of succinate under normal conditions, is low. In addition, succinate 
dehydrogenase is controlled in a subtle way by its potent inhibitor oxaloacetate. 
Therefore, elevated ROS generation accompanying succinate oxidation seems unlikely 
to be a major contributor to oxidative stress to mitochondria under normal metabolic 
conditions. However under conditions when glutamate is present very low levels of 
succinate are required for reverse electron flow to be achieved (Muller, Liu et al. 2008).  
 
Oxidative stress is proposed to be a major contributor to the aging process. ROS 
production is not the only important factor determining the level of oxidative stress. 
The ability to counteract ROS is of critical importance. To determine the capability of 
the mtDNA mutator mouse tissues to defend against oxidative stress we exposed 
tissues to ambient oxygen pressure and measured malonyl dialdehyde (MDA) 
formation. MDA is a by-product of lipid peroxidation. Mutator tissues showed 
significantly decreased capacity to protect against oxidation. 
This could be due to the redox state in the cell as a result of mitochondrial dysfunction. 
A more oxidized environment in the cell will not allow efficient elimination of ROS 
possibly due to lower pools of reduced glutathione and NADPH (Aon, Cortassa et al. 
2010). I addition to measuring the capacity of the tissues to defend against oxidative 
stress, we attempted to determine the mtDNA mutator mouse suffered from increased 
oxidative stress in vivo. This was done by measuring 4-hydroxynonenol (HNE) 
adducts, a marker of oxidative modification originating from lipid peroxidation of 
proteins.  In liver we detected a general increase in 4-HNE adducts however no such 
increase was found in the kidney. This could be due to a decreased antioxidant capacity 
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or possibly impaired energy demanding degradation and transport systems in the liver. 
In addition, the respiratory chain subunits produced by the mtDNA mutator 
mitochondria are likely misfolded (Edgar, Shabalina et al. 2009). This could increase 
their susceptibility to oxidative modification (Dukan, Farewell et al. 2000).  
 
Mitochondrial dysfunction can lead to the opening of the permeability transition pore 
(PTP). This causes the mitochondria to depolarize completely and can lead to 
apoptosis. Also it has been proposed that complex I dysfunction, which is seen in 
mtDNA mutator mice, due to mtDNA mutations can, not only lower membrane 
potential but also shift the voltage threshold for opening of the PTP, so that less 
reduction in membrane potential is needed in order to open the PTP (Porcelli, Angelin 
et al. 2009). Since increased apoptosis, complex I deficiency, and mitochondrial 
dysfunction is seen in the mtDNA mutator mice, we measured the spontaneous and 
inducible high amplitude swelling of mtDNA mutator mitochondria. There are several 
effectors that can sensitize mitochondria to depolarization such as palmitate, ROS and 
Ca2+. We assessed the sensitivity of liver and heart mitochondria to Ca2+. The 
mitochondria of the mtDNA mutator mice were surprisingly not extra sensitive to Ca2+ 
induced swelling. This suggests that more detailed studies are needed to determine the 
mechanisms of how mitochondrial dysfunction sensitizes mitochondria to 
permeabilization. 
 
Although the capacity to produce ROS is lower in the mtDNA mutator mice, the lack 
of sufficient ability to protect against oxidation may allow existing ROS to cause even 
greater harm. It is possible that under conditions were ROS production is exceptionally 
high this deficiency might lead to tissue damage and perhaps increased apoptosis as has 
been observed in our and a similar mouse model (Hiona, Sanz et al. ; Kujoth, Hiona et 
al. 2005; Niu, Trifunovic et al. 2007) This in conjunction with the cells inability to 
produce enough ATP when energy demands are high might very well conspire to 
overwhelm the capacity of the mtDNA mutator mice to maintain their tissues, leading 
to the observed premature aging phenotypes.  
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3.3 ON POINT MUTATIONS AND CELLULAR SENESCENCE 
In paper III we investigated how mtDNA mutations affect cellular senescence (Kukat, 
Edgar et al. 2011). Since the mtDNA mutator mice have a progeroid phenotype perhaps 
also the cells would senesce at an accelerated rate. Alternatively, since there is a strong 
correlation between mtDNA mutations and cancer, reviewed in (Chandra and Singh 
2011) the mtDNA mutations could cause a pro proliferation effect and let the cells 
escape from senescence. What we found was that cells grown in culture with ample 
access to glucose were able to escape senescence to a much higher degree than their wt 
counterparts. In fact almost all MEF cultures from the mtDNA mice went into 
spontaneous immortalization. This was only when the cells were grown in 20% oxygen 
in high glucose media. When cells were grown under more physiological conditions, in 
3% oxygen, this was not observed. Neither did the mtDNA mutator cells immortalize 
when grown in low glucose or galactose. Only under conditions with ample glucose 
and increased oxygen tension did the cells immortalize.   
 
In order for cells to continue to proliferate they must escape both apoptosis and 
senescence. That means they need to avoid the effects of the tumor suppressors 
pathways, which play an important role in both apoptosis and senescence. There are 
two major pathways involved in cellular senescence. The first involving p53, and the 
other involving pRB.  
 
p53 guards the genome against damage and can initiate DNA repair cell cycle arrest or 
even apoptosis if the damage proves severe. It is mutated in most cancers and crucial in 
preventing cancer growth. p53 is regulated by MDM2 which targets it for degradation. 
MDM2 can be inactivated by p19ARF leading to increased p53 activity. Downstream 
of p53 is p21, which is believed to be the main target of p53 mediating cell cycle arrest.  
 
RB mediates the transition from G1 phase to S phase when phosphorylated. RB 
phosphorylation is carried out by CDKs (Cyclin dependent kinases). P16 is a CDK 
inhibitor, which inhibits RB phosphorylation, and thereby the transition to S-phase 
(Lanigan, Geraghty et al. 2011). Earlier studies showed the importance of the 
p53/p19ARF pathway for the spontaneous immortlization of MEFs (Harvey and 
Levine 1991).  
 
We analyzed the levels of the tumor suppressors p53, p19, p21, and p16INK4 in early 
and late passages of wt and mtDNA mutator MEFs. p53 levels were significantly 
decreased in later passages in the mtDNA mutator MEFs whereas levels of p19 were 
decreased already at early passages. p16INK4 levels were decreased at early passages but 
increased to wt levels again at the later passages. The decreases in tumor suppressor 
levels likely contribute to the ability of mtDNA mutator MEFs to escape senescence. 
Even though levels of p16 and p19 are reduced in early passages, they are not 
significantly reduced in later passages that coincide with immortalization. Since p53 is 
the only tumor suppressor that is significantly lowered at later passages it seems most 
likely that this is what is responsible for the immortalization of the mtDNA mutator 
MEFs. However as p21 levels are not changed it would seem that the reduction of p53 
lets the cells escape senescence through a p21 independent pathway. This is possibly 
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due to that p21 is not essential for cellular senescence in MEFs (Pantoja and Serrano 
1999). That changes in tumor suppressors affected the cells capability to escape 
senescence seems clear. So what was behind these changes? 
 
One possibly explanation for the increased rate of immortalization is increased ROS 
production that might cause mutations in essential genes in the tumor suppressor 
pathways. No such increase in ROS production was found however, either using FACS 
analysis or confocal microscopy. Perhaps it is still possible that in a subset of cells there 
is increased ROS production causing the necessary mutations allowing 
immortalization.	  Alternatively	  mutations	  arise	  in	  both	  wt	  and	  mtDNA	  mutator	  cells	  but	  are	  not	   sufficient	   to	   induce	   immortalization	   (Fridman	  and	  Tainsky	  2008).	  A	  glycolytic	   shift	   could	   provide	   the	   extra	   step	   needed	   for	   immortalization.	   It	   is	  known	  that	  cancer	  cells	  often	  have	  increased	  glycolysis,	  a	  phenomena	  first	  noted	  by	  Otto	  Warburg	  more	  than	  80	  years	  ago.	  Whether	  it	  is	  the	  causative	  or	  simply	  a	  side	  effect	  of	  cancer	  growth	  has	  been	  the	  subject	  of	  some	  debate.	  However,	  there	  are	   several	   theoretical	   proposals	   and	   experimental	   data	   that	   do	   point	   to	   the	  Warburg	  effect	  playing	  an	  active	  role	  in	  cancer	  progression.	  One	  example	  comes	  from	  colon	  cancer	  cell	   lines	  were,	   induction	  of	  oxidative	  metabolism	  by	   frataxin	  inhibits	  cancer	  growth	  (Schulz,	  Thierbach	  et	  al.	  2006).	  However	  since	  no	  tumors	  were	  found	  in	  mtDNA	  mutator	  mice	  this	  might	  not	  be	  an	  important	  mechanism	  for	  them	  in	  vivo.	  Clearly	  cell	  culture	  conditions	  do	  not	  always	  accurately	  reflect	  what	  happens	  in	  vivo.	  However	  the	  study	  points	  to	  that	  aerobic	  glycolysis	  may	  have	  an	  effect	  on	  cellular	  proliferation,	  perhaps	  not	  only	  in	  cancer	  cells	  but	  also	  in	  normal	  tissues.	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3.4 THE ROLE OF UCP2 IN MTDNA MUTATOR MICE 
Various observations led us to examine what role UCP2 played in the phenotype of the 
mtDNA mutator mice. For example, at 25 weeks of age the mtDNA mutator mice 
weigh less than their wt littermates (Trifunovic, Wredenberg et al. 2004) however they 
eat 9% more. This discrepancy in food intake and weight gain could possibly be an 
effect of mitochondrial uncoupling. We also found an increase in UCP2 transcript 
levels in many tissues. In addition to this we saw an increase in UCP2 protein levels in 
spleen and lung. As UCP2 has been proposed to mediate proton leak, we measured 
membrane potential in wt and mtDNA mutator mitochondria. There was no difference 
in membrane potential in, spleen or liver mitochondria from wt or mtDNA mutator 
mice. 
 
To further examine the role of high UCP2 levels on mtDNA mutator phenotypes, we 
crossed mtDNA mutator mice with a UCP2KO mice, producing a mtDNA 
mutator;UCP2KO double mutant (DM) mice. We measured basal, state 4 and 
uncoupled respiration in spleenocytes of wt, UCP2KO, mtDNA mutator and DM mice. 
This gave us mice with 3 different levels of UCP2 expression: mtDNA mutator (high), 
wt (normal) and UCPKO (none) DM (none). The results showed that state 4 respiration 
was independent of UCP2 level. This strongly argues against an uncoupling role for 
UCP2 in our cells, since state 4 respiration is dependent on proton leak.  
 
Another proposed role for UCP2 is to mediate a switch from glucose to fatty acid 
metabolism (Pecqueur, Bui et al. 2008). If lower levels of CoA are generated from fatty 
acids, the cell will increase import of pyruvate into the mitochondria by increasing 
glycolysis. Increased glycolysis might be reflected on lactate production and blood 
glucose levels. We found that DM mice had high levels of lactate and low levels of 
glucose circulating in the blood. Also, DM spleenocytes showed a high level of lactate 
production. However, UCP2KO mice had very low levels of lactate circulating in blood 
and produced by spleenocytes. That UCP2KO mice have low levels of lactate could be 
explained by them using glucose instead of fatty acids for feeding the ETC. This would 
result in less pyruvate being available for lactate production. The fact that DM mice 
have high levels of lactate could be due to combination of trying to use glucose as a 
respiratory substrate while having damaged respiratory chain.  
 
Analysing gene expression in mtDNA mutator hearts we found many genes associated 
with metabolism up regulated. We also found up regulation of several genes indicating 
a switch to fatty acid metabolism, such as carnitine palmitoyl transferase 1 (CPT-1) and 
PDK4. It has been shown that CPT-1 is the rate limiting step in lipid oxidation as it 
confines the level of fatty acids transport into mitochondria (Gower, Nagy et al. 2002). 
PDK4 is the enzyme that inactivates the pyruvate dehydrogenase complex, a crucial 
step for the inhibition of the whole oxidation of glucose (Sugden and Holness 2006). 
Also the mtDNA mutator mice loose their fat tissue preferentially while maintaining 
their lean body mass. In addition they have higher levels of circulating fatty acids early 
in the onset of symptoms. Later when their fat stores are gone these levels are reduced 
to half of their wt littermates (Trifunovic, Wredenberg et al. 2004). The DM mutant 
mice however do not have reduced levels of circulating fatty acids even late in their 
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life. These finding together point to a switch in substrate utilization towards fatty acids. 
Additionally since effects of UCP2 ablation can be detected on the systemic level the 
metabolic effects of UCP2 on the organism are not negligible.  
 
If UCP2 is an uncoupling protein its effect on the mtDNA mutator mice could be either 
detrimental or beneficial. The same could be true if it regulates substrate utilization. If it 
is an uncoupling protein it might reduce ROS production by increasing proton leak. As 
was found in paper II, it seems as if mtDNA mutator tissues are more sensitive to 
oxygen exposure. Increasing proton leak might thus be a protective mechanism to 
reduce ROS produced from reverse electron flow. On the other hand damaged 
mitochondria already have trouble producing enough ATP. Letting part of the 
membrane potential dissipate as heat could exacerbate this problem leading to an 
energy crisis. Our data however does not support any of these hypotheses, since state 4 
respiration and membrane potential was independent of UCP2. If UCP2 regulates 
mitochondrial substrate utilization, a shift towards fatty acid utilization could be 
beneficial allowing the cell to use glucose for glycolysis were it does not need to rely 
on mitochondrial respiration. Alternatively the reliance on glycolysis could worsen the 
problem by leading to a relative energy deficient state (Sebastiani, Giordano et al. 
2007).  
 
As a consequence of UCP2 ablation we observed an increase in mitochondrial 
deficiency in DM hearts compared to mtDNA mutator hearts. Mitochondrial mass was 
increased and enzyme activity was reduced in DM hearts compared to the other 
genotypes. We also found a greatly increased number of cox-negative cells in 25-week-
old DM hearts. This cox negativity is not found in mtDNA mutator mice until 45 weeks 
of age. This suggests that up regulation or at the very least the presence of UCP2 does 
not worsen the situation but protects the mtDNA mutator heart from early dysfunction. 
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